Nitrogen-containing flavonoids as CDK1/Cyclin B inhibitors: Design, synthesis, and biological evaluation

被引:27
作者
Liu, Tao
Xu, Zhongmiao
He, Qiaojun
Chen, Yanhong
Yang, Bo
Hu, Yongzhou [1 ]
机构
[1] Zhejiang Univ, Sch Pharmaceut Sci, ZJU ENS Joint Lab Med Chem, Hangzhou 310031, Peoples R China
[2] Zhejiang Univ, Sch Pharmaceut Sci, Dept Pharmacol, Hangzhou 310031, Peoples R China
关键词
cyclin-dependent kinases (CDKs) inhibitor; antiproliferative activity; flavonoids; apoptosis;
D O I
10.1016/j.bmcl.2006.07.088
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of nitrogen-containing flavonoids 5a-1, 6a,b, and 7a,b were designed and synthesized as cyclin-dependent kinases (CDKs) inhibitors. The representative compounds 5a, 5b, 5e, and 5g showed potent CDK1/Cyclin B inhibitory activities. All compounds displayed a significant growth inhibitory action in vitro against Bel-7402, PC-3, ECA-109, A-549, HL-60, and MCF-7 cancer cell lines. Flow cytometry analysis showed that 5b induced apoptosis in PC-3 cells. (c) 2006 Published by Elsevier Ltd.
引用
收藏
页码:278 / 281
页数:4
相关论文
共 18 条
[1]  
Bu XY, 1997, SYNTHESIS-STUTTGART, P1246
[2]  
Gulati K.C., 1943, ORG SYNTH, V2, P522
[3]   Cyclin-dependent kinases [J].
Harper, JW ;
Adams, PD .
CHEMICAL REVIEWS, 2001, 101 (08) :2511-2526
[4]   Small molecules as inhibitors of cyclin-dependent kinases [J].
Huwe, A ;
Mazitschek, R ;
Giannis, A .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (19) :2122-2138
[5]  
JUNTEND KYT, 1988, Patent No. [292576, 0292576]
[6]  
Lee SK, 2002, ANTICANCER RES, V22, P97
[7]  
LI JF, 2002, HEILONGJIANG MED PHA, V25, P15
[8]   2′-Hydroxy-3′-(morpholin-4-yl-methyl)-4′,6′-dimethoxy-2-chloro-chalcone [J].
Liu, T ;
Xu, ZM ;
Hu, YZ .
ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 :O3389-O3390
[9]   Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities [J].
Moon, MJ ;
Lee, SK ;
Lee, JW ;
Song, WK ;
Kim, SW ;
Kim, JI ;
Cho, C ;
Choi, SJ ;
Kim, YC .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (01) :237-246
[10]  
MOSMAN T, 1983, J IMMUNOL METHODS, V55, P5563